Table 1. Demographic and clinicopathological characteristics of patients.
| Characteristics | No of patients (%) | |
| Adenomatous polyps | 9 | |
| In situ carcinomas | 11 | |
| Colorectal carcinomas - Study cohort | 60 | |
| Colorectal carcinomas - Validation cohort | 55 | |
| Study Cohort | Validation Cohort | |
| Sex, n (%) | ||
| - Male | 38 (63) | 39 (71) |
| - Female | 22 (37) | 16 (29) |
| Age (years) | ||
| - Mean ± SD | 72.7±9.2 | 68.8 ± 7.9 |
| - Median (range) | 72.5 (54-89) | 70 (39-80) |
| TNM Stage, n (%) | ||
| - I | 8 (13.3) | - |
| - II | 20 (33.4) | - |
| - III | 14 (23,3) | - |
| - IV | 18 (30.0) | 55 (100) |
| Grading, n (%) | ||
| - G1 | 11 (18.3) | 8 (15) |
| - G2 | 40 (66.7) | 37 (67) |
| - G3 | 9 (15.0) | 10 (18) |
| Tumor Site | ||
| - Right/transverse colon | 22 (37) | 10 (18) |
| - Left colon | 35 (58) | 40 (73) |
| - Not reported | 3 (5) | 5 (9) |
| Metastatic pattern, n (%) | ||
| - Liver | 17 (28) | 29 (53) |
| - Lung | 8 (13) | 23 (42) |
| - Peritoneum | 6 (10) | 6 (11) |
| - Other sites | 3 (5) | 3 (6) |
| Adjuvant chemotherapy (TNM stage II/III, %) | ||
| - Yes | 15 (42) | |
| - No | 21 (58) | |
| First line chemotherapy (TNM stage IV, %) | ||
| - Yes | 15 (83) | |
| - No | 3 (17) | 55 (100) |